Cannabis sativa L. - Botany and Biotechnology 图书pdf下载

Mahmoud A. ElSohly 博士是 ELI 的总裁兼实验室主任。他是美国国家天然产物研究中心、药物科学研究所的研究教授，以及密西西比大学药学院的药剂学教授。 ElSohly 博士是密西西比大学大麻项目的负责人，该项目由国家药物滥用研究所资助。 ElSohly 博士获得了学士学位。在药学和药物化学和硕士学位埃及开罗开罗大学药学和制药科学学士，博士学位。匹兹堡大学生药学博士。他获得了美国法医委员会 (BCFM) 和美国法医检查员学院 (BCFE) 的董事会认证。 ElSohly 博士拥有 30 多项涉及滥用药物的加工、测试和检测的专利，以及涉及用于治疗癌症和其他诊断领域的生物活性天然产物和组合物的其他专利。他撰写了 250 多篇学术文章，并在与药物发现、分析和代谢相关的专业学会科学会议上发表了 200 多篇演讲，他的许多文章都涉及滥用药物的法医问题。他经常在国家和国际科学会议上展示他的研究成果。他是许多学术科学协会的成员，并被《科学家》（1995 年 4 月 17 日）和《科学观察》（Science Watch）（1995 年 1 月）评为 1981 年至 1993 年间世界法医学领域被引用次数第二多的作者。 ElSohly 博士还被《分析毒理学杂志》（Journal of Analytical Toxicology，2004 年 10 月刊）评为 1981 年至 2003 年该杂志前十位（第 3 和第 4 位）被引用次数最多的作者和最多产的作者之一。

Cannabis sativa L. - Botany and Biotechnology 本书 pdf 阅读和下载 马哈茂德·萨赫利

This book highlights current Cannabis research: its botany, authentication, biotechnology, in vitro propagation, chemistry, cannabinoids biosynthesis, metabolomics, genomics, biomass production, quality control, and pharmacology. Cannabis sativa L. (Family: Cannabaceae) is one of the oldest sources of fiber, food and medicine. This plant has been of interest to researchers, general public and media not only due to its medicinal properties but also the controversy surrounding its illicit use. Cannabis has a long history of medicinal use in the Middle East and Asia, being first introduced as a medicine in Western Europe in the early 19th century. Due to its numerous natural constituents, Cannabis is considered a chemically complex species. It contains a unique class of terpeno-phenolic compounds (cannabinoids or phytocannabinoids), which have been extensively studied since the discovery of the chemical structure of tetrahydrocannabinol (Δ9-THC), commonly known as THC, the main constituent responsible for the plant’s psychoactive effects. An additionally important cannabinoid of current interest is Cannabidiol (CBD). There has been a significant interest in CBD and CBD oil (extract of CBD rich Cannabis) over the last few years because of its reported activity as an antiepileptic agent, particularly its potential use in the treatment of intractable epilepsy in children